Prospective cohort study of automated hybrid closed-loop insulin delivery systems during a two-day alpine ski camp in children and adolescents with type 1 diabetes.

Prospective cohort study of automated hybrid closed-loop insulin delivery systems during a two-day alpine ski camp in children and adolescents with type 1 diabetes. - InSki

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034007

Enrollment

Registered

2024-04-04

Start date

2024-01-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E10

Interventions

Group 1: Medtronic MiniMedTM AID Group 2: mylife Ypsopump CamAPS Group 3: Tandem t:slim Control IQ AID

Eligibility

Sex/Gender

All

Age

10 Years to 17 Years

Inclusion criteria

Inclusion criteria: Diagnosed with type 1 diabetes Signed consent form from a parent or other legal guardian Use of a hybrid closed-loop insulin delivery system Presence of basic movement skills in alpine skiing

Exclusion criteria

Exclusion criteria: Concurrent participation in another study. Receipt of an investigational drug within 1 week prior to screening in this study. Heart rate 9% (75mmol/mol) Significant abnormal ECG at screening, as assessed by the medical examiner. Any chronic (metabolic) disorder or serious illness other than type 1 diabetes mellitus that, in the opinion of the investigator, could jeopardize the participant's safety or compliance with the protocol.

Design outcomes

Primary

Measure	Time frame
TIRAID: Time in the target range (TIR, 70-180 mg/dL) in % comparing the two-day ski camp and the ten days before the ski camp.	—

Secondary

Measure	Time frame
TBRAID: Time below target range (TBR, 180 mg/dL) in % comparing the two-day ski camp and the ten days before the ski camp. TIRAIDvsAID: Time in the target range (TIR, 70-180 mg/dL) in % in comparison of the different AID systems during the two-day ski camp. TBRAIDvsAID: Time below target range (TBR, 180 mg/dL) in % in the comparison of the different AID systems during the two-day ski camp. MARDDex: %MARD of the Dexcom G7 CGM system during the two-day ski camp compared to a capillary blood glucose measurement as a reference value.	—

Measure

Time frame

TBRAID: Time below target range (TBR, 180 mg/dL) in % comparing the two-day ski camp and the ten days before the ski camp. TIRAIDvsAID: Time in the target range (TIR, 70-180 mg/dL) in % in comparison of the different AID systems during the two-day ski camp. TBRAIDvsAID: Time below target range (TBR, 180 mg/dL) in % in the comparison of the different AID systems during the two-day ski camp. MARDDex: %MARD of the Dexcom G7 CGM system during the two-day ski camp compared to a capillary blood glucose measurement as a reference value.

—

Countries

Austria, Germany

Contacts

Public ContactOthmar Moser

Universität Bayreuth

othmar.moser@uni-bayreuth.de+49 (0)921 / 55-3465

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026